Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5257418014 | Administration of mitotic inhibitor (procedure) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5257419018 | Administration of mitotic inhibitor | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Administration of mitotic inhibitor (procedure) | Is a | Introduction procedure (procedure) | true | Inferred relationship | Some | ||
| Administration of mitotic inhibitor (procedure) | Method | Administration - action | true | Inferred relationship | Some | 1 | |
| Administration of mitotic inhibitor (procedure) | Direct substance | Mitotic inhibitor | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Is a | True | Administration of mitotic inhibitor (procedure) | Inferred relationship | Some | |
| R-CEOP (rituximab, cyclophosphamide, etoposide, vincristine, prednisone) antineoplastic chemotherapy | Is a | True | Administration of mitotic inhibitor (procedure) | Inferred relationship | Some | |
| Dose-adjusted etoposide-prednisolone-oncovin-cyclophosphamide-hydroxydaunorubicin (regime/therapy) | Is a | True | Administration of mitotic inhibitor (procedure) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR